Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00283049
Status:
TERMINATED
Last Update Posted:
2011-01-13
First Post:
2006-01-26
Brief Title:
Insulin Glargine Injection Treatment in Place of Thiazolidinedione TZD Sulfonylurea or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus T2DM Adult Subjects With Unsatisfactory Control
Sponsor:
Organization:
Sanofi
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
390
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: